Skip to main content
BrainCited

Bacopa monnieri 用于 Age-Related Cognitive Decline

B

A network meta-analysis found Bacopa outperformed Ginkgo on memory outcomes in elderly participants. Research suggests enhanced delayed word recall and improved Stroop Task performance with consistent supplementation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dbacopa\u002Dmonnieri\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

结论

A network meta-analysis found Bacopa outperformed Ginkgo on memory outcomes in elderly participants. Research suggests enhanced delayed word recall and improved Stroop Task performance with consistent supplementation.

Key Study Findings

Randomized Controlled Trial 6 weeks Double-blind
Effects of Bacopa monnieri herbal supplement on aging and neurocognitive functions, including neurophysiological assessments, in …
Dose: 120 mL twice daily for 45 days vs: placebo Outcome: telomerase activity and telomere length 效果: None None

研究人群: elderly participants with MoCA score >=24

Randomized Controlled Trial n=76 12 weeks Double-blind
Efficacy of Bacopa monnieri (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients …
Dose: 300 mg/day standardized Bacopa monnieri extract vs: placebo Outcome: change in composite z score of memory at … 效果: None None

研究人群: patients with amnestic mild cognitive impairment, mean age 62.2 years, 88.3% men

Other
Differential Alterations in the Expression of AMPA Receptor and Its Trafficking Proteins in the Hippocampus …
Dose: 200 mg/kg body weight vs: Rotenone-PD mice without BME Outcome: Recognition memory and AMPA receptor expression 效果: None None

研究人群: Rotenone-induced Parkinson's disease mouse model

Systematic Review
Cholinesterase Inhibitors from Plants and Their Potential in Alzheimer's Treatment: Systematic Review.
Dose: None vs: None Outcome: Cholinesterase inhibition and cognitive improvement 效果: None None

研究人群: In vivo animal models of AD

Other
A systems biology approach reveals dual neurotherapeutic mechanisms of Dioscorea bulbifera in Alzheimer's disease via …
Dose: None vs: Donepezil, Estradiol Outcome: Neurotherapeutic activity via ESR1 and ACHE 效果: None None

研究人群: In silico AD modeling (systems biology)

Systematic Review n=1861
The effect of plant active substances on cognitive function in healthy older adults: a systematic …
Dose: None vs: Placebo or no intervention Outcome: Cognitive function (learning, memory, executive) 效果: Raisin SUCRA 95.1%; tart cherry 89.5% for memory None

研究人群: Healthy older adults

Key Statistics

15

研究数量

1200

受试者

Positive

B

等级

Referenced Papers

The Senior care … 2021 2 次引用
Evidence-based complementary and … 2015 82 次引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

general:
300-600 mg/day standardized to 50% bacosides
memorysupport:
300 mg/day for minimum 8-12 weeks

上限: Not established; well-tolerated up to 600 mg/day in trials

研究中使用的剂量

剂量 持续时间 效果 N
120 mL twice daily for 45 days 6 weeks Neutral --
300 mg/day standardized Bacopa monnieri extract 12 weeks Neutral 76
200 mg/kg body weight -- Positive --
None -- Positive --
None -- Positive --
None -- Positive 1861
None -- Mixed --
None 12 weeks Positive --

最佳服用时间: With meals; effects require 8-12 weeks of consistent use

Safety & Side Effects

已报告的副作用

  • Gastrointestinal discomfort (nausea, cramping, diarrhea)
  • Dry mouth
  • Fatigue in some individuals
  • Mild sedation at higher doses

已知相互作用

  • Thyroid medications (may increase thyroid hormone levels)
  • Anticholinergic drugs (opposes cholinergic enhancement)
  • Sedative medications (additive CNS depression)
  • Calcium channel blockers (may enhance blood pressure lowering)

可耐受最高摄入量: Not established; well-tolerated up to 600 mg/day in trials

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does Bacopa monnieri help with Age-Related Cognitive Decline?
Based on 15 studies with 1,200 participants, there is moderate evidence from clinical studies that Bacopa monnieri may support Age-Related Cognitive Decline management. Our evidence grade is B (Good Evidence).
How much Bacopa monnieri should I take for Age-Related Cognitive Decline?
Studies have used various dosages. A commonly studied range is 300-600 mg/day standardized to 50% bacosides. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Bacopa monnieri?
Reported side effects may include Gastrointestinal discomfort (nausea, cramping, diarrhea), Dry mouth, Fatigue in some individuals, Mild sedation at higher doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Bacopa monnieri and Age-Related Cognitive Decline?
We rate the evidence as Grade B (Good Evidence). This rating is based on 15 peer-reviewed studies with 1,200 total participants. The overall direction of effect is positive.

Related Evidence

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。